The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease
NCT ID: NCT02259049
Last Updated: 2016-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
6 participants
INTERVENTIONAL
2014-10-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contribution of L-Tyrosine to Human Decision Making in Stressful Situations
NCT04518254
Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males
NCT02214290
Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.
NCT06442293
Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive
NCT01816698
Effect of Antioxidant Supplementation on the Autonomic Balance
NCT03510221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a total of 3 visits with 24 hour ambulatory BP and HR monitoring.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-Tyrosine
We will administer 1,000 mg of L-tyrosine BID for 24 hours and record BP and HR.
L-tyrosine
Each subject will receive 2,000 mg of L-tyrosine BID for 24 hours.
Sugar Pill
Each subject will receive a sugar pill BID for 24 hours.
Sugar Pill
We will administer a sugar pill BID for 24 hours and record BP and HR.
L-tyrosine
Each subject will receive 2,000 mg of L-tyrosine BID for 24 hours.
Sugar Pill
Each subject will receive a sugar pill BID for 24 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-tyrosine
Each subject will receive 2,000 mg of L-tyrosine BID for 24 hours.
Sugar Pill
Each subject will receive a sugar pill BID for 24 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
3. mentally able to participate in the study
1. Pregnancy
2. any person who is currently taking amino acid supplements.
3. Any history of myocardial infarction, stent, or CABG
4. Phenylketonurics
5. Untreated hypertension
40 Years
84 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York Institute of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joanne DiFrancisco-Donoghue
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanne Donoghue, PhD
Role: PRINCIPAL_INVESTIGATOR
New York Institute of Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York Institute of Technology
Old Westbury, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BHS-1056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.